Table 1. Formulation approaches for ocular delivery.
Strategies |
Advantages |
Ref. |
Liposomes |
Enhance corneal absorption of the drug |
[74] |
Viscosity modification |
Improve ocular residence time |
[75] |
Niosomes |
Chemical stability, improve bioavailability, and lower toxicity |
[76] |
Microemulsion |
Increase drug solubility and corneal membrane permeability |
[77] |
Nanosuspension |
Improve drug solubility and bioavailability, negligible irritant property |
[78] |
Ocular implants |
The systemic side effects of the drug get reduced. Avoids restrictive blood ocular barrier. Releases medication for an extended period. |
[79] |
Insoluble inserts |
Increases ocular residence time. Targeted drug delivery to specific ocular tissues. Avoids sensitivity responses related to preservatives to reduce the need for them. |
[80] |
Soluble inserts |
Prolonged drug release and increased residence time. |
[81] |
Intravitreal injections |
Highest retinal and vitreal bioavailability. |
[82] |